Article thumbnail

Disfiguring Annular Sarcoidosis Improved by Adalimumab

By C.A. Kaiser, A. Cozzio, G.F.L. Hofbauer, J. Kamarashev, L.E. French and A.A. Navarini

Abstract

Depending on the location, dermatoses can produce blemishes that severely impair quality of life and require highly effective treatment that is otherwise used for extensive skin involvement. We report the case of a 39-year-old, otherwise healthy male disfigured by an 8 × 7-cm hypopigmented and centrally atrophic annular plaque with erythematous indurated borders in an area of scar tissue on his forehead. Skin biopsies revealed non-caseating granulomas, and hilar involvement was identified, leading to the diagnosis of systemic sarcoidosis stage II with cutaneous involvement. The lesions proved resistant to multiple therapies, but responded within 4 months to adalimumab with regression of the lesion and inflammatory infiltrate. The visual analogue scale of disease activity decreased from 7/10 to 3.5/10, and the Dermatology Life Quality Index from 16/30 to 3/30 points. In conclusion, TNF-α inhibition can control inflammation and disfigurement by cutaneous sarcoidosis and restore quality of life

Topics: Published: May 2011
Publisher: S. Karger AG
OAI identifier: oai:pubmedcentral.nih.gov:3104865
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Anadkat MJ: Recalcitrant cutaneous sarcoidosis responding to infliximab. Arch Dermatol
  2. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review (in Spanish).
  3. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
  4. Targeting the TNF-alpha pathway in sarcoidosis. Expert Opin Ther Targets 2010;14:21–29.
  5. (1992). Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice.